These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 16741656)

  • 21. Mathematical modelling of the transport of hydroxypropyl-β-cyclodextrin inclusion complexes of ranitidine hydrochloride and furosemide loaded chitosan nanoparticles across a Caco-2 cell monolayer.
    Sadighi A; Ostad SN; Rezayat SM; Foroutan M; Faramarzi MA; Dorkoosh FA
    Int J Pharm; 2012 Jan; 422(1-2):479-88. PubMed ID: 22101294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transepithelial transport mechanisms of 7,8-dihydroxyflavone, a small molecular TrkB receptor agonist, in human intestinal Caco-2 cells.
    Chen Y; Xue F; Xia G; Zhao Z; Chen C; Li Y; Zhang Y
    Food Funct; 2019 Aug; 10(8):5215-5227. PubMed ID: 31384856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Permeation of Acamprosate Is Predominantly Caused by Paracellular Diffusion across Caco-2 Cell Monolayers: A Paracellular Modeling Approach.
    Antonescu IE; Rasmussen KF; Neuhoff S; Fretté X; Karlgren M; Bergström CAS; Nielsen CU; Steffansen B
    Mol Pharm; 2019 Nov; 16(11):4636-4650. PubMed ID: 31560549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stereoselective and multiple carrier-mediated transport of cetirizine across Caco-2 cell monolayers with potential drug interaction.
    He Y; Liu Y; Zeng S
    Chirality; 2010 Jul; 22(7):684-92. PubMed ID: 20014242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancing Oral Bioavailability of Cyclic RGD Hexa-peptides by the Lipophilic Prodrug Charge Masking Approach: Redirection of Peptide Intestinal Permeability from a Paracellular to Transcellular Pathway.
    Schumacher-Klinger A; Fanous J; Merzbach S; Weinmüller M; Reichart F; Räder AFB; Gitlin-Domagalska A; Gilon C; Kessler H; Hoffman A
    Mol Pharm; 2018 Aug; 15(8):3468-3477. PubMed ID: 29976060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carrier-mediated uptake of H2-receptor antagonists by the rat choroid plexus: involvement of rat organic anion transporter 3.
    Nagata Y; Kusuhara H; Hirono S; Endou H; Sugiyama Y
    Drug Metab Dispos; 2004 Sep; 32(9):1040-7. PubMed ID: 15319347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paracellular calcium transport across Caco-2 and HT29 cell monolayers.
    Blais A; Aymard P; Lacour B
    Pflugers Arch; 1997 Jul; 434(3):300-5. PubMed ID: 9178630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional characterization of peptide transporters in MDCKII-MDR1 cell line as a model for oral absorption studies.
    Agarwal S; Jain R; Pal D; Mitra AK
    Int J Pharm; 2007 Mar; 332(1-2):147-52. PubMed ID: 17097248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs.
    Dahan A; Amidon GL
    Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paracellular drug transport across intestinal epithelia: influence of charge and induced water flux.
    Karlsson J; Ungell A; Gråsjö J; Artursson P
    Eur J Pharm Sci; 1999 Oct; 9(1):47-56. PubMed ID: 10493996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. pH-dependent functional activity of P-glycoprotein in limiting intestinal absorption of protic drugs: kinetic analysis of quinidine efflux in situ.
    Varma MV; Panchagnula R
    J Pharm Sci; 2005 Dec; 94(12):2632-43. PubMed ID: 16258992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Limited influence of P-glycoprotein on small-intestinal absorption of cilostazol, a high absorptive permeability drug.
    Toyobuku H; Tamai I; Ueno K; Tsuji A
    J Pharm Sci; 2003 Nov; 92(11):2249-59. PubMed ID: 14603510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Photoaffinity labeling of the anionic sites in Caco-2 cells mediating saturable transport of hydrophilic cations ranitidine and famotidine.
    Bourdet DL; Lee K; Thakker DR
    J Med Chem; 2004 May; 47(11):2935-8. PubMed ID: 15139772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Why Does the Intestine Lack Basolateral Efflux Transporters for Cationic Compounds? A Provocative Hypothesis.
    Proctor WR; Ming X; Bourdet D; Han TK; Everett RS; Thakker DR
    J Pharm Sci; 2016 Feb; 105(2):484-496. PubMed ID: 26869413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of HT29-18-C1 and Caco-2 cell lines as models for studying intestinal paracellular drug absorption.
    Collett A; Sims E; Walker D; He YL; Ayrton J; Rowland M; Warhurst G
    Pharm Res; 1996 Feb; 13(2):216-21. PubMed ID: 8932439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of P-glycoprotein-mediated efflux and the potential involvement of an influx transport process contributing to the intestinal uptake of deltamethrin, cis-permethrin, and trans-permethrin.
    Zastre J; Dowd C; Bruckner J; Popovici A
    Toxicol Sci; 2013 Dec; 136(2):284-93. PubMed ID: 24014652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonlinear intestinal absorption of 5-hydroxytryptamine receptor antagonist caused by absorptive and secretory transporters.
    Tamai I; Saheki A; Saitoh R; Sai Y; Yamada I; Tsuji A
    J Pharmacol Exp Ther; 1997 Oct; 283(1):108-15. PubMed ID: 9336314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The transport of gastrodin in Caco-2 cells and uptake in Bcap37 and Bcap37/MDR1 cells.
    Wang XD; Zeng S
    Yao Xue Xue Bao; 2010 Dec; 45(12):1497-502. PubMed ID: 21348420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting phenolic acid absorption in Caco-2 cells: a theoretical permeability model and mechanistic study.
    Farrell TL; Poquet L; Dew TP; Barber S; Williamson G
    Drug Metab Dispos; 2012 Feb; 40(2):397-406. PubMed ID: 22096083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acetaminophen inhibits intestinal p-glycoprotein transport activity.
    Novak A; Carpini GD; Ruiz ML; Luquita MG; Rubio MC; Mottino AD; Ghanem CI
    J Pharm Sci; 2013 Oct; 102(10):3830-7. PubMed ID: 23897240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.